JPS62145016A - Antibacterial agent - Google Patents
Antibacterial agentInfo
- Publication number
- JPS62145016A JPS62145016A JP28458485A JP28458485A JPS62145016A JP S62145016 A JPS62145016 A JP S62145016A JP 28458485 A JP28458485 A JP 28458485A JP 28458485 A JP28458485 A JP 28458485A JP S62145016 A JPS62145016 A JP S62145016A
- Authority
- JP
- Japan
- Prior art keywords
- agent
- dermatic
- antibacterial agent
- indigenous
- active component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は抗菌剤に関する。詳しくは、皮膚常在菌に対し
て抑ルJ効果を示す抗菌剤に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to an antibacterial agent. Specifically, the present invention relates to an antibacterial agent that exhibits an inhibitory effect on resident skin bacteria.
(発明の構成)
本発明者等は、各種の植物中に含まれる生理活性物質の
薬理活性について検討を行った結果、ある種のフラボノ
イド化合物が、皮膚常在菌である、スタフィロコツ力ス
エビデルミデス< 江■hb−a匹町並」」IBJ〉に
対して優れた抗菌力を示すことを確認し本発明を達成し
た。(Structure of the Invention) As a result of studying the pharmacological activities of physiologically active substances contained in various plants, the present inventors found that certain flavonoid compounds are associated with Staphylococcus aevidermides, a resident skin bacteria. ■The present invention was achieved by confirming that it exhibits excellent antibacterial activity against HBJ.
本発明の詳細な説明するに、本発明の有効成分であるフ
ラボノイド(Flavonoid)化合物としては、5
.7−シヒドロキシー4−メトキシイソフラボン(Bi
ochanin A、化合物 l)、ゴ、 4’、 5
、7−チトラヒ ゛ドロキシフラバノン(Er1di
octyol、化合物2)、又はl−xビガロカテキン
(J’ −Epigal Iocatechin、化合
物3)が挙げられる。To explain the present invention in detail, the flavonoid compounds that are the active ingredients of the present invention include 5
.. 7-cyhydroxy-4-methoxyisoflavone (Bi
ochanin A, compound l), go, 4', 5
, 7-thitrahydroxyflavanone (Er1di
octyol, compound 2), or l-x bigalocatechin (J'-Epigal Iocatechin, compound 3).
これ等の化合物は例えば8iochelIIical
Pharaa−cology、32巻、7号、1141
〜114B頁 (1983年)又はTetrached
ron、 29巻、125頁(1973年)等に記載さ
れている周知の物質であり、これ等の化合物は植物中に
存在し、例えばl−エピガロカテキンは、つるぐみの茎
皮から単離される。These compounds are, for example, 8iochelIIical
Pharaa-cology, Volume 32, No. 7, 1141
~page 114B (1983) or Tetrached
Ron, Vol. 29, p. 125 (1973), etc., and these compounds exist in plants. It will be done.
上述のフラボノイド化合物は単離された純品である必要
はなく、これ等を含む抽出物、部分精製物等が使用され
、通常はこれ等有効成分を適当な基剤、希釈剤等と共に
、全量中0.01〜!重量%程度含有するようにして使
用される。The above-mentioned flavonoid compounds do not need to be isolated and pure products, but extracts, partially purified products, etc. containing them are used, and usually these active ingredients are mixed with appropriate bases, diluents, etc. in total amount. Medium 0.01~! It is used in such a way that it contains about % by weight.
(発明の効果)
これ等のフラボン化合物は後記実施例に示すよう:こ、
皮膚常在菌であるスタフィロコッカス エビデルミデス
に対し有効な抗菌力を示す。それ故、これ等の化合物
は、この菌と、例えばプロピオニバクテリウム アクネ
ス(Pro 1onibact、er’u口困)とによ
る直接的刺激と、これ等の菌のリパーゼ作用によって生
した遊離脂肪酸の刺激作用の両者が関与していると思わ
れる、皮膚疾患例えは尋常性座そう(にきび、Acne
Vulgaris )の予防、治療等に有用である。(Effect of the invention) These flavone compounds are as shown in the examples below:
Shows effective antibacterial activity against Staphylococcus evidermides, a resident bacteria on the skin. Therefore, these compounds are effective against direct stimulation of these bacteria, such as Propionibacterium acnes, and stimulation of free fatty acids produced by the lipase action of these bacteria. An example of a skin disease in which both effects are thought to be involved is acne vulgaris.
Vulgaris) is useful for prevention, treatment, etc.
本発明の抗菌剤を使用する場合、基剤及び添加剤として
、油分、水、界面活性剤、アルコール、キレート剤、酸
化防止剤、増粘剤、色素、防腐剤等が使用され、溶液状
、乳化状、粉末状、分散状等の形態で使用される。When using the antibacterial agent of the present invention, oil, water, surfactant, alcohol, chelating agent, antioxidant, thickener, pigment, preservative, etc. are used as a base and additives, and in the form of a solution, It is used in forms such as emulsion, powder, and dispersion.
(実施例、) 以下本発明を実施例について更に詳細に説明する。(Example,) The present invention will be described in more detail below with reference to Examples.
[抗菌性試験]
下記に示す、寒天平板希釈法(Agar diluti
onmethod )により本物質の抗苗活性を測定し
た。[Antibacterial test] Agar plate dilution method shown below.
The anti-seedling activity of this substance was measured using the onmethod.
即ち、試料化合物を5%のジメチルスルホキシド水溶液
に懸濁させ、所定濃度とした試料溜)α1m1 を滅菌
シャーレ(9cm X 2cm )に採り、これに予め
120℃で 15分間滅菌処理した感受性ディスク用
培地(栄研化学社製)9mlを加えて充分混合し平板固
化した。That is, a sample compound α1m1 was suspended in a 5% dimethyl sulfoxide aqueous solution to a predetermined concentration, and a sample reservoir α1m1 was placed in a sterile petri dish (9 cm x 2 cm), and a culture medium for susceptible discs that had been previously sterilized at 120°C for 15 minutes was placed there. (manufactured by Eiken Chemical Co., Ltd.) 9 ml was added, thoroughly mixed, and solidified on a flat plate.
内径1mmの白金耳を用い予め調製した試験菌を上述の
平板上に、長さ 2cm程度塗布して接種し、30℃で
18〜20時間培養した。試験菌の発育が完全に阻止
された最小の試料溶液濃度をもって旧C値(mi旧mu
m 1nhibitory concentratio
n )とした。Test bacteria prepared in advance using a platinum loop with an inner diameter of 1 mm were spread and inoculated onto the above-mentioned flat plate to a length of about 2 cm, and cultured at 30°C for 18 to 20 hours. The old C value (mi old mu
m 1nhibitory concentration
n).
なお、試験菌はハートインツユジョンブイヨン培地(栄
研化学社製)を用いて30 ℃、18〜20’時間培養
し使用直前に生理活性食塩水で 100倍に希釈したも
のを用いた。The test bacteria were cultured at 30° C. for 18 to 20 hours using heart infusion broth medium (manufactured by Eiken Kagaku Co., Ltd.) and diluted 100 times with physiologically active saline immediately before use.
上記の試験法により スタフィロコッカス エピデルミ
デス(o e ’d rm’dis、 ATCC
12228)に対する各試料化合物の旧C値を測定した
結果は、次頁の表1の通りであった。By the above test method, Staphylococcus epidermides (o e 'd rm'dis, ATCC
The results of measuring the old C value of each sample compound against 12228) are shown in Table 1 on the next page.
表1Table 1
Claims (1)
ボン、3′,4′,5,7−テトラヒドロキシフラバノ
ン及びl−エピガロカテキンから選ばれたフラボノイド
化合物を有効成分とする、皮膚常在菌に対して抑制効果
を示す抗菌剤。(1) Skin resident bacteria whose active ingredients are flavonoid compounds selected from 5,7-dihydroxy-4'-methoxyisoflavone, 3',4',5,7-tetrahydroxyflavanone, and l-epigallocatechin. An antibacterial agent that shows an inhibitory effect on
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28458485A JPS62145016A (en) | 1985-12-18 | 1985-12-18 | Antibacterial agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28458485A JPS62145016A (en) | 1985-12-18 | 1985-12-18 | Antibacterial agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62145016A true JPS62145016A (en) | 1987-06-29 |
Family
ID=17680345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP28458485A Pending JPS62145016A (en) | 1985-12-18 | 1985-12-18 | Antibacterial agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62145016A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0499015A1 (en) * | 1991-02-15 | 1992-08-19 | Fockerman, Jasmine | Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
WO1994023717A1 (en) * | 1993-04-20 | 1994-10-27 | The Procter & Gamble Company | Methods of using hesperetin for sebum control and treatment of acne |
KR100729732B1 (en) | 2006-01-19 | 2007-06-20 | 건국대학교 산학협력단 | 5,7,3',4'-tetrahydoxy flavanone having protective activity on the uv-induced cell death in human keratinocytes |
US20120141617A1 (en) * | 2008-07-25 | 2012-06-07 | Mary Kay Inc. | Compositions comprising docynia delavajy extract and/or elaeagnus lancelotus extract |
US9724278B2 (en) | 2008-06-13 | 2017-08-08 | Colgate-Palmolive Company | Oral compositions and uses thereof |
-
1985
- 1985-12-18 JP JP28458485A patent/JPS62145016A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0499015A1 (en) * | 1991-02-15 | 1992-08-19 | Fockerman, Jasmine | Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
WO1994023717A1 (en) * | 1993-04-20 | 1994-10-27 | The Procter & Gamble Company | Methods of using hesperetin for sebum control and treatment of acne |
US5587176A (en) * | 1993-04-20 | 1996-12-24 | The Procter & Gamble Company | Methods of using hesperetin for sebum control and treatment of acne |
KR100729732B1 (en) | 2006-01-19 | 2007-06-20 | 건국대학교 산학협력단 | 5,7,3',4'-tetrahydoxy flavanone having protective activity on the uv-induced cell death in human keratinocytes |
US9724278B2 (en) | 2008-06-13 | 2017-08-08 | Colgate-Palmolive Company | Oral compositions and uses thereof |
US20120141617A1 (en) * | 2008-07-25 | 2012-06-07 | Mary Kay Inc. | Compositions comprising docynia delavajy extract and/or elaeagnus lancelotus extract |
US9040104B2 (en) * | 2008-07-25 | 2015-05-26 | Mary Kay Inc. | Compositions comprising Docynia delavajy extract and/or Elaeagnus lancelotus extract |
US9498427B2 (en) | 2008-07-25 | 2016-11-22 | Mary Kay Inc. | Compositions comprising Elaeagnus lancelotus extract |
US9808417B2 (en) | 2008-07-25 | 2017-11-07 | Mary Kay Inc. | Compositions comprising Docynia delavajy extract and/or Elaeagnus lancelotus extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100374099C (en) | Antimicrobial composition | |
JP4408563B2 (en) | Antibacterial composition | |
JPH06509564A (en) | antibacterial mixture | |
EP0223681B1 (en) | Alcohol-based antimicrobial compositions and method for enhancing their efficacity | |
JPS5944313A (en) | Antibacterial composition | |
Reddish | Methods of testing antiseptics | |
JP2005200339A (en) | Antimicrobial agent | |
BR112021007347A2 (en) | BIOFLAVONOID COMPOSITIONS AND THEIR USE FOR WATER PURIFICATION AND FOOD PRESERVATION | |
JPS62145016A (en) | Antibacterial agent | |
JP2012500195A (en) | Gentle, non-irritating, non-alcoholic skin antiseptic | |
Sekar et al. | Formulation and evaluation of natural anti-acne cream containing Syzygium samarangense fruits extract | |
EP1027827A1 (en) | Disinfectant composition | |
JPS5940122B2 (en) | Oxydiacetaldehyde substances | |
KR20040062561A (en) | Anti-microbial composition comprising a metal ion cheating agent | |
Martineau et al. | Biofilm reduction by a new burn gel that targets nociception | |
JPH032105A (en) | Stabilizer composition and stabilized aqueous system | |
JPS62145017A (en) | Antibacterial agent | |
JP3577113B2 (en) | External preparation for skin | |
KR20210101000A (en) | Composition having sterilzation and anti-influenza virus effect | |
JP2013071896A (en) | Toxin production inhibitor for microorganism | |
Rahman et al. | In vitro antimicrobial potency of lemon fruit (Citrus limon) extract on Salmonella Typhi | |
JP2006111577A (en) | Germicidal agent containing vegetable essential oil component and method for preventing infectious disease by using the germicidal agent | |
RU2292919C1 (en) | Agent for skin integument disinfection | |
KR100822416B1 (en) | Fragrance composition with antimicrobial effect and cosmetic composition comprising the same | |
JP2001064163A (en) | Antimicrobial agent |